All research
2026-07-02 PubMed

Fc-fused IdeS enzyme enables rapid, contamination-free generation of F(ab')2 fragments from human IgG

Fast Generation of F(Ab')2 Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.

Background

The generation of F(ab')2 fragments from intact immunoglobulin G (IgG) is crucial for many research and therapeutic applications, particularly when Fc-mediated effector functions are undesirable. Fc regions can trigger immune responses, interfere with assays, or cause non-specific binding. Traditional methods for Fc removal often involve enzymatic digestion (e.g., pepsin) followed by purification steps, which can be time-consuming, inefficient, and risk contamination with the degrading enzyme. There's a need for a streamlined, efficient method to produce pure F(ab')2 fragments or Fc-free proteins.

Study Design

Researchers developed a three-step protocol for generating F(ab')2 fragments from human IgG or Fc-fusion proteins using an IdeS-Fc enzyme. First, target IgG or Fc-fusion proteins were incubated with IdeS-Fc. Second, the resulting Fc fragments, along with the IdeS-Fc enzyme itself (due to its Fc fusion), were retained using protein G agarose beads. This step leverages protein G's affinity for Fc regions. Third, the desired F(ab')2 fragments or Fc-free proteins were collected by centrifugation, effectively separating them from the retained Fc fragments and the IdeS-Fc enzyme in the original buffer.

Results

The developed method successfully achieved the rapid and efficient generation of F(ab')2 fragments from human IgG and Fc-fusion proteins. A key advantage of this approach is the complete removal of the IgG-degrading enzyme, IdeS-Fc, from the final product. This eliminates potential contamination issues often associated with traditional enzymatic digestion methods, ensuring the purity of the F(ab')2 fragments. The use of protein G agarose beads proved effective in simultaneously capturing both the cleaved Fc fragments and the IdeS-Fc enzyme itself, simplifying the purification process. The method yielded Fc-free proteins that were collected by centrifugation in their original buffer, indicating minimal processing and potential for maintaining protein integrity. This streamlined process offers a significant improvement in efficiency and purity for generating antibody fragments.

The method ensures the F(ab')2 fragments or Fc-free proteins are collected in the original buffer without IdeS contamination, a critical benefit for downstream applications.

Key Findings

  • IdeS-Fc enzyme effectively cleaves human IgG and Fc-fusion proteins into F(ab')2 fragments.
  • Protein G agarose beads efficiently capture both Fc fragments and the IdeS-Fc enzyme.
  • The method yields F(ab')2 fragments free from IdeS enzyme contamination.
  • Fc-free proteins are collected in their original buffer, simplifying purification.

Why It Matters

This novel method significantly streamlines the production of F(ab')2 fragments, offering a faster and cleaner alternative to conventional techniques. For researchers and biotech companies developing antibody-drug conjugates, bispecific antibodies, or diagnostic tools, this means quicker turnaround times and higher purity products, reducing experimental variability and improving therapeutic safety profiles. The ability to easily remove Fc regions is also critical for studies investigating antibody mechanisms where Fc-mediated effects need to be excluded. This protocol could become a standard laboratory technique, simplifying the preparation of Fc-free proteins for various applications, from basic research to preclinical development, by providing a robust, contamination-free approach.


ides igg fab2 fragments protein purification antibody engineering enzyme
Source: pubmed:42387944 · Ingested 2026-07-02 · Digest: gemini-2.5-flash